Experience

GBS Venture Partners

• Australia
• Venture Capital and Private Equity Principals
• 1 - 100 Employee

• Founder and Managing Director

  • 1998 - Present

  Melbourne, Australia An Australian life science venture capital firm, GBS is focussed on helping talented entrepreneurs build great life science technologies.



Amber Electric

• Australia
• Services for Renewable Energy
• 1 - 100 Employee

• Non Executive Director

  • Sep 2020 - Present

  Melbourne, Victoria, Australia Power to the people Our goal at Amber is to help customers save money while powering the transition to renewable energy. The Amber model is a cheaper way to buy power and the fastest way for Australia to reach 100% renewable energy.



Platinum Asset Management

• Australia
• Investment Management
• 100 - 200 Employee

• Non Executive Director

  • Mar 2018 - Present

  Sydney, Australia Platinum is an Australia-based investment manager that focuses on one asset class – international shares, or, more simply put, we provide portfolios of listed companies from around the world. Platinum offers only one core investment style – we seek out companies whose true worth and prospects are yet to be fully recognised by the market. ASX:PTM has $27bn funds under management.



Social Ventures Australia

• Australia
• Civic and Social Organizations
• 100 - 200 Employee

• Investment Committee Member, Diversified Impact Fund

  • Sep 2017 - Present

  Melbourne, Australia Social Ventures Australia works with partners to improve the lives of people in need in Australia. The SVA Diversified Impact Fund is a social impact investment fund offering investors the opportunity to generate financial returns while making a meaningful social impact on the lives of people in Australia.



KiwiNet

• New Zealand
• Research
• 1 - 100 Employee

• Investment Committee Member

  • Oct 2020 - Present

  18 research organisations working towards 1 common goal… transforming scientific discoveries into new business, for all. New Zealand’s the only place in the world where public research organisations voluntarily join forces, and pool funding, to get their best research discoveries investor ready. We do it for the good of our country. We share a common goal of increasing the scale and impact of science and technology-based innovation, to maximise economic benefits to New Zealand.



Moximed

• United States
• Medical Equipment Manufacturing
• 1 - 100 Employee

• Non Executive Director

  • Jan 2017 - Present

  San Francisco Bay Area New joint sparing device to help ageing knees feel better and last longer.



AllVascular

• Australia
• Medical Equipment Manufacturing
• 1 - 100 Employee

• Non Executive Director

  • Jun 2021 - Mar 2023

  Sydney, New South Wales, Australia AllVascular is an Australian medical device company based in Sydney. The Company’s lead product is a novel arterial access system called the AVAS®. The AVAS® is unique because it enables the isolated and targeted delivery of anti-cancer agents, such as chemotherapy, to cancerous organs, repeatedly, thereby reducing side effects and improving efficacy.



Elastagen Pty Ltd

• Australia
• Medical Device

• Non Executive Director

  • Jan 2015 - Apr 2018

  Sydney, Australia Elastagen is a clinical stage medical company with an advanced pipeline of products based on the human protein tropoelastin, a pioneering medical biomaterial. Acquired by Allergan for up to USD$260m in the second quarter of 2018.



Non Executive Director

• Neurovance

  • Jan 2015 - Mar 2017

  Greater Boston Area Neurovance is a clinical stage neuroscience-focused company working to develop a novel approach to help adults and children with ADHD, Attention Deficit Hyperactivity Disorder. Acquired for USD $1bn by Otsuka in early 2017.



AirXpanders

• United States
• Medical Equipment Manufacturing
• 1 - 100 Employee

• Non Executive Director

  • 2010 - Jun 2016

  Sunnyvale ASX listed AirXpanders® is a U.S.-based medical device company focused on the design, manufacturing, and distribution of AeroForm®, a revolutionary patient-controlled tissue expander system used in patients undergoing breast reconstruction following a mastectomy. The AeroForm is able to significantly improve the often painful process of preparing for breast reconstruction via a faster and less invasive method that moves beyond the limitations of conventional saline-based tissue expanders.



Viveve, Inc.

• Chair and Non Executive Director

  • 2007 - 2016

  Palo Alto NASDAQ listed Viveve has a radio frequency procedure to treat women's health problems. Developed through to global regulatory approvals and sales.



KaloBios

• Non Executive Director

  • 2004 - 2013

  South San Francisco Kalobios developed antibody drugs to treat respiratory, inflammatory and oncology diseases through to phase 2 clinical development, with a NASDAQ listing.



Proacta, Inc

• Non Executive Director

  • 2004 - 2012

  Greater San Diego Area Proacta developed small molecule hypoxia activated pro-drugs for the treatment of a number of different cancers through to phase 2 clinical development.



Dynamic Hearing

• Computers and Electronics Manufacturing

• Non Executive Director

  • 2002 - 2011

  Melbourne, Australia Dynamic Hearing developed software for digital hearing aids and other hearing tools such as head sets. Acquired by Wolfson.



Melbourne Business School

• Australia
• Higher Education
• 300 - 400 Employee

• Adjunct Senior Lecturer, Financing Entrepreneurial Ventures

  • 2000 - 2011

  Melbourne, Australia Taught a second year half semester course which I developed based on financing technology based entrepreneurial ventures in Australia, based on case studies of many of Australia's most exciting companies.



Syntara

• Biotechnology
• 1 - 100 Employee

• Non Executive Director

  • 1999 - 2007

  Sydney Founding chair and founding investor. Pharmaxis is a pharmaceutical research company focussed on inflammation and fibrosis with a portfolio of products at various stages of development and approval. In 2015 Pharmaxis signed a signature deal with Boehringer Ingelheim to develop a Pharmaxis drug discovery for the treatment of inflammatory diseases.



Bain & Company

• United States
• Business Consulting and Services
• 700 & Above Employee

• Associate Consultant

  • 1989 - 1992